MARK COX ANAESTHESIA LTD

Executive Summary

MARK COX ANAESTHESIA LTD is financially robust with excellent liquidity and steadily growing equity, reflecting strong operational health in its specialist medical practice. The company’s balance sheet shows no distress symptoms, and it complies fully with filing obligations. To sustain and build on this healthy position, management should focus on growth opportunities while maintaining tight control over cash flow and operational risks.

MARK COX ANAESTHESIA LTD - Analysis Report

Company Number: 13028817

Analysis Date: 2025-07-20 13:29 UTC

Financial Health Assessment: MARK COX ANAESTHESIA LTD

---

1. Financial Health Score: Grade A

Explanation:
MARK COX ANAESTHESIA LTD demonstrates a robust financial position with strong liquidity, positive net current assets, and consistent growth in shareholders' funds over the past five years. The company shows no signs of financial distress, reflected in its healthy working capital and increasing equity base. The absence of liabilities beyond short-term creditors and no overdue filings further support a top-grade assessment.

---

2. Key Vital Signs

Metric	2024 Value (£)	Interpretation
Current Assets	271,353	High level of liquid or near-liquid assets, indicating good cash or receivables position.
Current Liabilities	20,891	Low short-term obligations relative to assets, manageable payable amounts.
Net Current Assets	250,462	Strong positive working capital, meaning the company can comfortably meet short-term debts.
Shareholders Funds	250,462	Equity has grown steadily from £58,249 in 2020, indicating retained earnings and/or capital injections.
Account Category	Micro	Simplified reporting but still shows important financial health indicators.
Filing Status	Up to date	No overdue accounts or confirmation statements, reflecting compliance and good governance.
Employee Numbers	Nil	No employees, suggesting low overhead costs but possibly reliant on directors or contractors.

Interpretation:
The company’s balance sheet "vital signs" resemble a healthy pulse: current assets comfortably exceed liabilities by over 12 times, implying strong liquidity and no liquidity crunch symptoms. The steady increase in net current assets and shareholders’ funds signals ongoing profitability or capital strengthening. The absence of employees reduces fixed cost pressures but may limit operational scalability.

---

3. Diagnosis

MARK COX ANAESTHESIA LTD is in excellent financial health, showing no symptoms of distress such as liquidity shortages, excessive debt, or shrinking equity. The company operates in a specialist medical practice sector and maintains a clean balance sheet with increasing net assets year-on-year. The positive trend in working capital suggests healthy cash flow management — akin to a patient with a strong heartbeat and stable vital signs.

There are no indications of financial strain, overdue obligations, or governance issues. The lack of employees suggests a lean operational model, likely dependent on the professional services of the two directors who are medical doctors. This lean model can be both a strength (low fixed costs) and a vulnerability (dependency on few individuals).

---

4. Recommendations

• Maintain Strong Liquidity: Continue the prudent management of current assets and liabilities to preserve the company's healthy cash flow.
• Plan for Growth: Consider strategies to diversify income or expand services, potentially hiring staff or contractors to increase capacity without overextending financially.
• Risk Management: Develop contingency plans to mitigate risks associated with reliance on key individuals (directors).
• Regular Financial Reviews: Maintain regular internal reviews of financial health to detect any early symptoms of financial distress.
• Explore Capital Utilisation: With strong equity, the company might explore investment in fixed assets or technology to enhance service delivery and operational efficiency.
• Compliance Vigilance: Continue timely filing of accounts and statutory returns to avoid penalties and maintain company reputation.

---